JME Society for Endocrinology Archive
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Journal of Molecular Endocrinology (2005) 34 859-863    DOI: 10.1677/jme.1.01760
© 2005 Society for Endocrinology

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Jennings, C E
Right arrow Articles by Pearce, S H S
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jennings, C E
Right arrow Articles by Pearce, S H S

A haplotype of the CYP27B1 promoter is associated with autoimmune Addison’s disease but not with Graves’ disease in a UK population

C E Jennings, C J Owen, V Wilson and S H S Pearce

Institute of Human Genetics, School of Clinical Medical Sciences, University of Newcastle, Newcastle upon Tyne, UK

(Requests for offprints should be addressed to Simon Pearce, Institute of Human Genetics, Centre for Life, Central Parkway, Newcastle upon Tyne NE1 3BZ, UK; Email: s.h.s.pearce{at}ncl.ac.uk)

Previous studies have suggested an association between alleles of the CYP27B1 (1-{alpha} hydroxylase) gene and autoimmune conditions. We have examined three single nucleotide polymorphisms (SNPs) that are located in the 5' region and promoter of the CYP27B1 gene for association in a cohort of Graves’ disease and autoimmune Addison’s disease subjects from the UK. Genomic DNA samples from white patients with autoimmune Addison’s disease (n=104) and healthy controls (n=464) were genotyped by PCR-RFLP analysis for the SNPs at positions –1260 and –1077 5' of the coding CYP27B1 sequences. The –1260 SNP was also examined in a cohort of patients with Graves’ disease (n=446). {chi}2 testing of contingency tables was used to determine the significance of genotypes and alleles. Haplotype frequencies and linkage disequilibrium measures were estimated using the UNPHASED and HAPLOVIEW packages. Alleles at the three CYP27B1 markers were in tight linkage disequilibrium with each other and all showed association with autoimmune Addison’s disease. The maximum evidence for association was with the –1260 C allele (76.0% in Addison’s subjects versus 64.9% in controls; P=0.003; odds ratio 1.71 (5–95% confidence intervals, 1.20–2.44). A global test of significance for the common –1918 T, –1260 C and –1077 G haplotype was significant in Addison’s subjects compared with controls (P=0.01). In contrast, there was no association of alleles at the –1260 SNP with Graves’ disease. We are able to confirm that a CYP27B1 promoter allele is associated with autoimmune Addison’s disease, and extend this finding to include an associated promoter haplotype.




This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
B. Novakovic, M. Sibson, H. K. Ng, U. Manuelpillai, V. Rakyan, T. Down, S. Beck, T. Fournier, D. Evain-Brion, E. Dimitriadis, et al.
Placenta-specific Methylation of the Vitamin D 24-Hydroxylase Gene: IMPLICATIONS FOR FEEDBACK AUTOREGULATION OF ACTIVE VITAMIN D LEVELS AT THE FETOMATERNAL INTERFACE
J. Biol. Chem., May 29, 2009; 284(22): 14838 - 14848.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
C. Diorio, M. Sinotte, J. Brisson, S. Berube, and M. Pollak
Vitamin D Pathway Polymorphisms in Relation to Mammographic Breast Density
Cancer Epidemiol. Biomarkers Prev., September 1, 2008; 17(9): 2505 - 2508.
[Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
B. Skinningsrud, E. S. Husebye, S. H. Pearce, D. O. McDonald, K. Brandal, A. B. Wolff, K. Lovas, T. Egeland, and D. E. Undlien
Polymorphisms in CLEC16A and CIITA at 16p13 Are Associated with Primary Adrenal Insufficiency
J. Clin. Endocrinol. Metab., September 1, 2008; 93(9): 3310 - 3317.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2005 by the Society for Endocrinology.